Cagas, Loella Brielle L.
HRN: 27-87-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2025
CEFUROXIME 1.5GM (VIAL)
12/17/2025
12/23/2025
IV
320mg
Q8
PCAP
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes